Landscapes / Targets

VEGFR2

18 drugs act on VEGFR2, in 50 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs18

DrugHow it worksCompanyStageNext dateDetails
Kinase inhibitor
Pfizer · Public PFE
Approved 31 Dec 2026Phase 3 trial completes
VEGFR2 antibody
Eli Lilly · Public LLY
Approved May 2027Phase 2 trial completes
—
Hengrui · Public 600276.SS
Approved in China Jul 2027Phase 2 trial completes
Kinase inhibitor
Approved 1 Feb 2028Phase 1/2 trial completes
Kinase inhibitor
Approved 27 Apr 2028Phase 2 trial completes
Tyrosine kinase inhibitor
Approved in China 31 May 2028Phase 2/3 trial completes
Monoclonal antibody
Akeso · Public 9926.HK
Phase 3 Nov 2026soonPhase 3 trial completes
Tyrosine kinase inhibitor
Phase 3 15 Dec 2026soonPhase 3 trial completes
—
Phase 3 30 Dec 2026Phase 3 trial completes
Tyrosine kinase inhibitor
Phase 3 30 Jan 2027Phase 1/2 trial completes
—
Phase 3 Oct 2027Phase 3 trial completes
—
Phase 2 Dec 2026Phase 1/2 trial completes
PD-1/VEGFR2 bifunctional antibody
Ottimo Pharma · Private
Phase 1/2 Dec 2028Phase 1/2 trial completes
—
Phase 1/2 —
—
AstraZeneca · Public AZN
Phase 2 —
—
Phase 1 30 Dec 2026Phase 1 trial completes
—
Phase 1 7 Mar 2027Phase 1 trial completes
—
Phase 1 Jun 2027Phase 1 trial completes

About this list

Checked
18 of 18 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow VEGFR2

Following is part of Solo: you see every change to VEGFR2 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in